Literature DB >> 31693891

Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.

Tabitha C Ting1, Maria Goralski2, Katherine Klein2, Baiyun Wang2, Jiwoong Kim3, Yang Xie3, Deepak Nijhawan4.   

Abstract

Indisulam and related sulfonamides recruit the splicing factor RBM39 to the CRL4-DCAF15 E3 ubiquitin ligase, resulting in RBM39 ubiquitination and degradation. Here, we used a combination of domain mapping and random mutagenesis to identify domains or residues that are necessary for indisulam-dependent RBM39 ubiquitination. DCAF15 mutations at Q232 or D475 prevent RBM39 recruitment by indisulam. RBM39 is recruited to DCAF15 by its RRM2 (RNA recognition motif 2) and is ubiquitinated on its N terminus. RBM23, which is an RBM39 paralog, is also recruited to the CRL4-DCAF15 ligase through its RRM2 domain and undergoes sulfonamide-dependent degradation. Indisulam alters the expression of more than 3,000 genes and causes widespread intron retention and exon skipping. All of these changes can be attributed to RBM39, and none are the consequence of RBM23 degradation. Our findings demonstrate that indisulam selectively degrades RBM23 and RBM39, the latter of which is critically important for splicing and gene expression.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRL4; DCAF15; RBM23; RBM39; sulfonamides

Mesh:

Substances:

Year:  2019        PMID: 31693891      PMCID: PMC7950731          DOI: 10.1016/j.celrep.2019.09.079

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  31 in total

1.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

2.  NGS QC Toolkit: a toolkit for quality control of next generation sequencing data.

Authors:  Ravi K Patel; Mukesh Jain
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

3.  An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases.

Authors:  Michael Hans Olma; Marcia Roy; Thierry Le Bihan; Izabela Sumara; Sarah Maerki; Brett Larsen; Manfredo Quadroni; Matthias Peter; Mike Tyers; Lionel Pintard
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

4.  Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.

Authors:  Georg Petzold; Eric S Fischer; Nicolas H Thomä
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

5.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

6.  KEGG: new perspectives on genomes, pathways, diseases and drugs.

Authors:  Minoru Kanehisa; Miho Furumichi; Mao Tanabe; Yoko Sato; Kanae Morishima
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

7.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

8.  Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.

Authors:  Eric Wang; Sydney X Lu; Alessandro Pastore; Xufeng Chen; Jochen Imig; Stanley Chun-Wei Lee; Kathryn Hockemeyer; Yohana E Ghebrechristos; Akihide Yoshimi; Daichi Inoue; Michelle Ki; Hana Cho; Lillian Bitner; Andreas Kloetgen; Kuan-Ting Lin; Taisuke Uehara; Takashi Owa; Raoul Tibes; Adrian R Krainer; Omar Abdel-Wahab; Iannis Aifantis
Journal:  Cancer Cell       Date:  2019-02-21       Impact factor: 31.743

Review 9.  Drugging the undruggables: exploring the ubiquitin system for drug development.

Authors:  Xiaodong Huang; Vishva M Dixit
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

10.  Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system.

Authors:  Mainak Guharoy; Pallab Bhowmick; Mohamed Sallam; Peter Tompa
Journal:  Nat Commun       Date:  2016-01-06       Impact factor: 14.919

View more
  15 in total

Review 1.  Dysregulation and therapeutic targeting of RNA splicing in cancer.

Authors:  Robert F Stanley; Omar Abdel-Wahab
Journal:  Nat Cancer       Date:  2022-05-27

Review 2.  Discovering new biology with drug-resistance alleles.

Authors:  Allyson M Freedy; Brian B Liau
Journal:  Nat Chem Biol       Date:  2021-11-19       Impact factor: 16.174

3.  Rational discovery of molecular glue degraders via scalable chemical profiling.

Authors:  Sophie Bauer; Matthias Brand; Cristina Mayor-Ruiz; Zuzanna Kozicka; Marton Siklos; Hana Imrichova; Ines H Kaltheuner; Elisa Hahn; Kristina Seiler; Anna Koren; Georg Petzold; Michaela Fellner; Christoph Bock; André C Müller; Johannes Zuber; Matthias Geyer; Nicolas H Thomä; Stefan Kubicek; Georg E Winter
Journal:  Nat Chem Biol       Date:  2020-08-03       Impact factor: 15.040

Review 4.  Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.

Authors:  Tao Wu; Hojong Yoon; Yuan Xiong; Sarah E Dixon-Clarke; Radosław P Nowak; Eric S Fischer
Journal:  Nat Struct Mol Biol       Date:  2020-06-15       Impact factor: 15.369

Review 5.  Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.

Authors:  Max Jan; Adam S Sperling; Benjamin L Ebert
Journal:  Nat Rev Clin Oncol       Date:  2021-03-02       Impact factor: 66.675

Review 6.  PROTACs: An Emerging Therapeutic Modality in Precision Medicine.

Authors:  Dhanusha A Nalawansha; Craig M Crews
Journal:  Cell Chem Biol       Date:  2020-08-13       Impact factor: 9.039

7.  Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4DCAF15 E3 Ligase.

Authors:  Sung Ah Kim; Seung-Hyun Jo; Jin Hwa Cho; Min Yeong Yu; Ho-Chul Shin; Jung-Ae Kim; Sung Goo Park; Byoung Chul Park; Sunhong Kim; Jeong-Hoon Kim
Journal:  Mol Cells       Date:  2020-11-30       Impact factor: 5.034

8.  A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues.

Authors:  Satoshi Yamanaka; Yuto Horiuchi; Saya Matsuoka; Kohki Kido; Kohei Nishino; Mayaka Maeno; Norio Shibata; Hidetaka Kosako; Tatsuya Sawasaki
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

Review 9.  Advancing targeted protein degradation for cancer therapy.

Authors:  Brandon Dale; Meng Cheng; Kwang-Su Park; H Ümit Kaniskan; Yue Xiong; Jian Jin
Journal:  Nat Rev Cancer       Date:  2021-06-15       Impact factor: 60.716

Review 10.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.